Clinical Trials in Denver

Showing 17901-17920 of 18,161 trials

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

NCT00052182

HIV-1-infected patients who have been treated with anti-HIV drugs for a long time may have weakened immune responses to HIV. The DNA-based vaccine in this study is designed to boost the immune system's responses against many HIV-1 proteins. The main purposes of this study are to test the safety of this HIV vaccine (EP HIV-1090) and to test whether the vaccine can stimulate immune system responses in people who have HIV-1 infection.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Oct 2002

Denver, Colorado, United States

COMPLETEDPhase 2/3< 1 mile

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

The primary purpose of this Phase II/III study is to demonstrate that Kamada-API, a new API concentrate manufactured by Kamada Ltd., is comparable to a currently marketed API product.

Alpha 1-Antitrypsin Deficiency

Kamada, Ltd.50 participantsStarted Mar 2007

Denver, Colorado, United States • Gainesville, Florida, United States • Tyler, Texas, United States

COMPLETEDPhase 2< 1 mile

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

NCT00306254

To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery

Venous Thrombosis

Pfizer1,225 participantsStarted Mar 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Little Rock, Arkansas, United States +131 more locations

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Find Trials by Condition in Denver

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Sleepiness and the Risk of Falling

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting

"A Multicenter Study Comparing the Clinical Outcomes of the Nuss and Ravitch Procedures for Repair Of Pediatric Pectus Excavatum

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

A Study of Lobucavir in Patients With AIDS

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia